Algert Global LLC trimmed its stake in Omega Healthcare Investors, Inc. (NYSE:OHI - Free Report) by 31.8% in the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 159,502 shares of the real estate investment trust's stock after selling 74,308 shares during the period. Algert Global LLC owned 0.05% of Omega Healthcare Investors worth $7,605,000 at the end of the most recent quarter.
Other hedge funds have also recently made changes to their positions in the company. BlackRock Inc. purchased a new position in shares of Omega Healthcare Investors in the 2nd quarter worth approximately $1,838,155,000. State Street Corp lifted its position in Omega Healthcare Investors by 4.8% during the second quarter. State Street Corp now owns 14,591,873 shares of the real estate investment trust's stock valued at $534,792,000 after acquiring an additional 671,473 shares during the last quarter. Geode Capital Management LLC boosted its stake in Omega Healthcare Investors by 9.4% in the fourth quarter. Geode Capital Management LLC now owns 8,515,924 shares of the real estate investment trust's stock valued at $377,648,000 after acquiring an additional 734,774 shares in the last quarter. Bank of New York Mellon Corp acquired a new stake in Omega Healthcare Investors in the second quarter valued at approximately $275,230,000. Finally, Invesco Ltd. boosted its stake in Omega Healthcare Investors by 8.6% in the fourth quarter. Invesco Ltd. now owns 5,368,945 shares of the real estate investment trust's stock valued at $238,059,000 after acquiring an additional 424,024 shares in the last quarter. 65.25% of the stock is currently owned by hedge funds and other institutional investors.
Analyst Ratings Changes
A number of equities analysts have recently issued reports on OHI shares. Scotiabank reduced their price target on Omega Healthcare Investors from $50.00 to $47.00 and set a "sector perform" rating on the stock in a research report on Thursday, June 18th. Raymond James Financial initiated coverage on Omega Healthcare Investors in a research report on Tuesday, June 16th. They issued an "outperform" rating and a $50.00 price objective for the company. Barclays initiated coverage on Omega Healthcare Investors in a research note on Tuesday, July 7th. They set an "underweight" rating and a $51.00 target price on the stock. BMO Capital Markets reaffirmed a "market perform" rating and set a $52.00 target price on shares of Omega Healthcare Investors in a research report on Monday, May 4th. Finally, Weiss Ratings raised Omega Healthcare Investors from a "buy (b)" rating to a "buy (b+)" rating in a research report on Tuesday, June 30th. Six research analysts have rated the stock with a Buy rating, seven have given a Hold rating and two have issued a Sell rating to the stock. According to MarketBeat.com, Omega Healthcare Investors presently has a consensus rating of "Hold" and an average price target of $49.21.
View Our Latest Analysis on OHI
Omega Healthcare Investors Price Performance
Shares of OHI opened at $47.02 on Thursday. The firm has a market capitalization of $14.25 billion, a PE ratio of 16.79, a price-to-earnings-growth ratio of 1.90 and a beta of 0.57. Omega Healthcare Investors, Inc. has a 1-year low of $39.26 and a 1-year high of $52.39. The company's fifty day moving average price is $48.28 and its 200-day moving average price is $47.09.
Omega Healthcare Investors (NYSE:OHI - Get Free Report) last issued its earnings results on Wednesday, July 29th. The real estate investment trust reported $1.19 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.51 by $0.68. The company had revenue of $328.25 million during the quarter, compared to analyst estimates of $266.97 million. Omega Healthcare Investors had a return on equity of 15.76% and a net margin of 66.96%.The firm's quarterly revenue was up 16.2% on a year-over-year basis. During the same quarter last year, the business posted $0.77 EPS. Omega Healthcare Investors has set its FY 2026 guidance at 3.220-3.260 EPS. As a group, research analysts anticipate that Omega Healthcare Investors, Inc. will post 3.12 EPS for the current fiscal year.
Omega Healthcare Investors Increases Dividend
The business also recently disclosed a quarterly dividend, which was paid on Friday, August 14th. Shareholders of record on Monday, August 3rd were paid a dividend of $0.68 per share. This represents a $2.72 dividend on an annualized basis and a dividend yield of 5.8%. The ex-dividend date was Monday, August 3rd. This is an increase from Omega Healthcare Investors's previous quarterly dividend of $0.67. Omega Healthcare Investors's dividend payout ratio (DPR) is 97.14%.
Omega Healthcare Investors Profile
(
Free Report)
Omega Healthcare Investors, Inc is a real estate investment trust (REIT) that specializes in the ownership and management of healthcare-related facilities. The company's core business involves acquiring and leasing long-term care properties, including skilled nursing facilities and assisted living communities, under net lease agreements. Its portfolio is designed to provide stable, inflation-protected cash flows from operators responsible for day-to-day property management.
Founded in 1992 and headquartered in Hunt Valley, Maryland, Omega Healthcare Investors has grown its holdings to encompass hundreds of facilities across the United States, with a smaller presence in select international markets.
Featured Stories
Want to see what other hedge funds are holding OHI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Omega Healthcare Investors, Inc. (NYSE:OHI - Free Report).
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Before you consider Omega Healthcare Investors, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Omega Healthcare Investors wasn't on the list.
While Omega Healthcare Investors currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we’ll send you MarketBeat’s list of ten stocks set to soar in Summer 2026, despite the threat of tariffs and what's happening in Iran. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
